Company Filing History:

6 out of 2,076

Janssen Pharmaceutica Nv

patents

5 out of 363

Ortho-mcneil Pharmaceutical Corp.

patents

1 out of 832,680

Other

patents

Years Active: 2001-2013

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8367825 - Substituted pyrimidinyl oxime kinase inhibitors (2013-02-05),

2. 8299082 - 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives (2012-10-30),

3. 8153791 - Substituted pyrimidinyl oxime kinase inhibitors (2012-04-10),

4. 7888380 - 1,2,4-Triazolylaminoaryl (heteroaryl) sulfonamide derivatives (2011-02-15),

5. 7605154 - Substituted Thiazolo [4,5-d]pyrimidines as protein kinase inhibitors (2009-10-20),

6. 7384979 - Substituted amino acids as erythropoietin mimetics (2008-06-10),

7. 7317031 - Substituted triazole diamine derivatives as kinase inhibitors (2008-01-08),

8. 7153869 - Substituted amino acids as erythropoietin mimetics (2006-12-26),

9. 7109220 - Amino substituted pyridinyl methanone compounds useful in treating kinase disorders (2006-09-19),

10. 6924302 - Substituted triazole diamine derivatives as kinase inhibitors (2005-08-02),

11. 6750369 - Substituted amino acids as erythropoietin mimetics (2004-06-15),

12. 6310078 - Substituted amino acids as erythropoietin mimetics (2001-10-30),

Title: Steven K Wetter: Innovator in Pharmaceutical Chemistry

Introduction

Steven K Wetter is a prominent inventor based in Flemington, NJ (US), known for his significant contributions to pharmaceutical chemistry. He holds a total of 12 patents, showcasing his innovative approach to developing new therapeutic compounds.

Latest Patents

Among his latest patents, Wetter has developed substituted pyrimidinyl oxime kinase inhibitors. This invention focuses on substituted pyrimidine compounds, which are designed for the treatment, prevention, or amelioration of chronic or acute protein kinase-mediated diseases, disorders, or conditions. Another notable patent involves 1,2,4-triazolylaminoaryl (heteroaryl) sulfonamide derivatives. These compounds possess cell cycle inhibitory activity, making them useful in anti-cancer applications.

Career Highlights

Wetter has worked with reputable companies in the pharmaceutical industry, including Janssen Pharmaceutica and Ortho-McNeil Pharmaceutical Corporation. His work in these organizations has contributed to the advancement of drug development and therapeutic solutions.

Collaborations

Throughout his career, Wetter has collaborated with notable professionals, including Peter J Connolly and Steven A Middleton. These partnerships have fostered innovation and enhanced the impact of his research.

Conclusion

Steven K Wetter's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the development of new therapeutic agents.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.